Methods for monitoring the quality of the new pharmaceutical substance 4-methyl-2,6-diisobornylphenol (dibornol) were developed.
Similar content being viewed by others
References
Y. Ruixing, R. Al-Ghazali, L. Wenwu, and W. Jinzhen, Scand. J. Clin. Lab. Invest., 66(7), 549 – 558 (2006).
S. Merat, M. Aduli, R. Kazemi, et al., Dig. Dis. Sci., 53(8), 2246 – 2250 (2008).
I. S. Ivanov, Proceedings of the Conference “Current Problems in Experimental and Clinical Pharmacology” [in Russian], Tomsk (2007), pp. 35 – 37.
Russian Federation patent No. 2347561 (2007).
M. V. Plotnikov, V. I. Smol’yakova, I. S. Ivanov, et al., Byull. Éksperim. Biol. Med., 145(3), 296 – 298 (2008).
I. Yu. Chukicheva and A. V. Kuchin, Ros. Khim. Zh., 48(3), 21 – 36 (2004).
The United States Pharmacopeia XXIX (2005).
British Pharmacopeia (2004).
European Pharmacopeia (2002).
Russian State Pharmacopeia [in Russian], Meditsina, Moscow (2007).
T. N. Pliev, Molecular Spectroscopy [in Russian], Iriston, Vladikavkaz (2001), Vol. 2.
USSR State Pharmacopeia [in Russian], Meditsina, Moscow (1987), Edition XI, Vol. 1: General Analytical Methods.
USSR State Pharmacopeia [in Russian], Meditsina, Moscow (1990), Edition XI, Vol. 2: General Analytical Methods. Plant Raw Materials.
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 45, No. 1, pp. 53 – 56, January, 2011.
Rights and permissions
About this article
Cite this article
Krasnov, E.A., Nazmutdinova, E.E., Ivanov, I.S. et al. Development of methods for the analysis of the new sterically hindered phenol dibornol as a pharmaceutical substance. Pharm Chem J 44, 639–641 (2011). https://doi.org/10.1007/s11094-011-0536-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-011-0536-8